"Da Vinci Code” Author Dan Brown Shares Mom’s Story, Advocates for Cancer Research at Ohio State

Dan Brown, author of best-sellers like “The Da Vinci Code,” shared the story of his mother’s brave battle against leukemia – including the life-extending treatment she received at OSUCCC – James – during a recent trip to The Ohio State University. Read More

Dan Brown, author of best-sellers like “The Da Vinci Code,” shared the story of his mother’s brave battle against leukemia – including the life-extending treatment she received at OSUCCC – James – during a recent trip to The Ohio State University. Read More

‘Miracle Drug’ Gives Patient Hope, She Pays it Forward By Raising $25K for Cancer Research

When Susan Davenport registered to ride in Pelotonia 2016 she had no idea that the bulk of clinical research behind her “miracle drug” was done at the OSUCCC - James, and received funding from Pelotonia. Read More

When Susan Davenport registered to ride in Pelotonia 2016 she had no idea that the bulk of clinical research behind her “miracle drug” was done at the OSUCCC - James, and received funding from Pelotonia. Read More

“Queen of the Mountain” Defies All Odds – Raises Funds and Participates In Pelotonia 15

Sue Zurface will participate in her 3rd Pelotonia ride despite her battle against CLL. Cycling, especially with her daughter Marissa, helps keep her motivated to do more in her fight against cancer. Read More

Sue Zurface will participate in her 3rd Pelotonia ride despite her battle against CLL. Cycling, especially with her daughter Marissa, helps keep her motivated to do more in her fight against cancer. Read More

Pelotonia-Supported Clinical Trial Returns Patient to Active Lifestyle

Wally Yocum, has a biology degree from Fairleigh-Dickinson University in New Jersey that he pursued partly because he thought, “Maybe I could help find a cure for something.” Read More

Wally Yocum, a technical manager at the Marietta branch of Koroseal Interior Products, LLC, has a biology degree from Fairleigh-Dickinson University in New Jersey that he pursued partly because he thought, “Maybe I could help find a cure for something." Years later, he did just that by participating in clinical trials for patients with chronic lymphocytic leukemia (CLL) at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James). Read More

Ibrutinib: Drug Approved for Chronic Leukemia

On her 70th birthday in June 2012, Judy Hileman, a Kansas native with a PhD in nursing, was diagnosed with chronic lymphocytic leukemia (CLL). Read More

On her 70th birthday in June 2012, Judy Hileman, a Kansas native with a PhD in nursing, was diagnosed with chronic lymphocytic leukemia (CLL). After two chemotherapy regimens failed, Hileman’s condition worsened to ultra-high risk CLL, and her oncologists searched for clinical trials around the nation that might help her. Hileman opted for a Pelotonia-funded phase II clinical trial at Ohio State of the drug ibrutinib. Read More